Back to Search
Start Over
Talazoparib (Tala) in patients (pts) with colorectal cancer (CRC) with BRCA1/2 mutations (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
- Source :
- Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p106-106, 235p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 174954212
- Full Text :
- https://doi.org/10.1200/JCO.2024.42.3_suppl.106